Loos; Petra

Patent Applications and Registrations

Patent applications and USPTO patent grants for Loos; Petra.The latest application filed is for "stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives".

Company Profile

3.5.18

Loos; Petra - Frankfurt am Main DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20220040267 - Bley; Oliver ; et al.	2022-02-10
Stabilized Pharmaceutical Formulations Of Insulin Aspart App 20220023392 - Bley; Oliver ; et al.	2022-01-27
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20210077589 - BLEY; Oliver ; et al.	2021-03-18
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20200297852 - Bley; Oliver ; et al.	2020-09-24
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives Grant 10,610,595 - Bley , et al.	2020-04-07
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20180125981 - Bley; Oliver ; et al.	2018-05-10
Stabilized Pharmaceutical Formulations Of Insulin Aspart App 20180125944 - Bley; Oliver ; et al.	2018-05-10
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20180125945 - Bley; Oliver ; et al.	2018-05-10
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20180125943 - BLEY; Oliver ; et al.	2018-05-10
Stabilized pharmaceutical formulations of insulin aspart Grant 9,895,423 - Bley , et al. February 20, 2	2018-02-20
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives Grant 9,895,424 - Bley , et al. February 20, 2	2018-02-20
Stable Formulation of Insulin Glulisine App 20180036411 - Loos; Petra ; et al.	2018-02-08
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives Grant 9,839,692 - Bley , et al. December 12, 2	2017-12-12
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives Grant 9,839,675 - Bley , et al. December 12, 2	2017-12-12
Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives App 20150216941 - Bley; Oliver ; et al.	2015-08-06
Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives App 20150216981 - Bley; Oliver ; et al.	2015-08-06
Stabilized Pharmaceutical Formulations Of Insulin Aspart App 20150190475 - Bley; Oliver ; et al.	2015-07-09
Stable Formulation of Insulin Glulisine App 20150119323 - Loos; Petra ; et al.	2015-04-30
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20140221285 - BLEY; Oliver ; et al.	2014-08-07
Long-acting Insulin Formulations App 20140206611 - Becker; Reinhard ; et al.	2014-07-24
Long-acting Formulations Of Insulins App 20120122774 - Becker; Reinhard ; et al.	2012-05-17
Long-acting Formulations Of Insulins App 20110301081 - Becker; Reinhard ; et al.	2011-12-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.